Lynne D. Berry

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations

Medicine, Genetics, Oncology +17

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Lynette M. Sholl, Dara L. Aisner, Marileila Varella‐Garcia et al. · Journal of Thoracic Oncology · 2015 · 430 citations · Full text

Medicine, Genetics, Oncology +16

Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps

Bob Chen, Cherie’ R. Scurrah, Eliot T. McKinley et al. · Cell · 2021 · 341 citations · Full text

Medicine, Cancer Biology, Oncology +17

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

Badi El Osta, Madhusmita Behera, Sungjin Kim et al. · Journal of Thoracic Oncology · 2019 · 241 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

Dale Han, Jonathan S. Zager, Yu Shyr et al. · Journal of Clinical Oncology · 2013 · 223 citations

Medicine, Oncology, Surgery +17